Press Release

Panorama NIPT achieves 2 million test milestone

Awarded positive Medicare coverage for serial use in Stage II & III CRC

Awarded positive Medicare coverage for serial use in Stage II & III CRC

Date	Title
01/09/20	Natera Statement Regarding CareDx Suit
01/09/20	Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera™ Patients with Stage II-III Colorectal Cancer
01/08/20	Natera To Webcast Live Presentation at the 38th Annual J.P. Morgan Healthcare Conference
01/06/20	Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents

You are here